Article Details

Switching to Rituximab Biosimilars is Safe, Effective for Patients With Oncohematological Diseases

Retrieved on: 2024-12-05 20:08:49

Tags for this article:

Click the tags to see associated articles and topics

Switching to Rituximab Biosimilars is Safe, Effective for Patients With Oncohematological Diseases. View article details on hiswai:

Excerpt

Rituximab is a monoclonal antibody ... By using monoclonal antibodies, advanced treatment methods have emerged, creating more options for patients.

Article found on: www.centerforbiosimilars.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo